Safety and efficacy of preoperative chemotherapy with SOX+Cetuximab in patients with liver-only metastases(H2,H3), KRAS-WT from colorectal cancer(KSCC1002)
收藏NIAID Data Ecosystem2026-03-06 收录
官方服务：
资源简介：
Interventions: L-OHP 130mg/m2 i.v. (day1) Cmab 250mg/m2 i.v. (only the first time Cmab 400mg/m2) S-1 80mg/m2 (day1-14) to be repeated every 3 weeks for 4 cycles. Surgery was planned after SOX+Cetuximab therapy. Primary outcome(s): Liver resection rate Study Design: Single arm Non-randomized
创建时间：
2010-10-15
